Different Wiping Motions in Phlebotomy

The Effect of Different Wiping Motions in Phlebotomy on Vein Visibility, Procedural Success and Phlebotomy-related Complications

This study was conducted with 90 patients. The phlebotomy site was wiped with circular motion in the group-I, vertical movement in the group-II, and first vertical and then circular motion in the group-III.

Study Overview

• Status: Completed
• Conditions: Nurse's Role
• Intervention / Treatment: Other: circular motion; Other: vertical motion; Other: circular+vertical motion

Detailed Description

Aim: This study was conducted to evaluate the effects of different wiping motions used in phlebotomy on vein visibility, procedural success, and phlebotomy-related complications.

Background: In phlebotomy practice, many application guidelines or textbooks are used. In these references, it is seen that phlebotomy site is wiped with different motions.

Methods: This study was conducted with 90 patients. The phlebotomy site was wiped with circular motion in the group-I, vertical movement in the group-II, and first vertical and then circular motion in the group-III.

• Study Type: Interventional
• Enrollment (Actual): 90
• Phase: Not Applicable

Contacts and Locations

Study Locations

• Turkey
  • Kayseri, Turkey, 38039
    • Erciyes University

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 18 years and older (Adult, Older Adult)
• Accepts Healthy Volunteers: Yes
• Genders Eligible for Study: All

Description

Inclusion Criteria:

• who are over 18 years old,
• without any psychiatric diseases,
• without vision or hearing problems,
• hospitalized in the internal medicine clinic,
• with platelet counts of 200 000 / mm³ and above,
• 8 cc of blood is ordered for lab test and
• individuals who volunteered to participate in the study

Exclusion Criteria:

• having a local or systemic infection,
• having vascular disease,
• having an immunopathological problem,
• scarring, psoriasis, active dermatitis in the phlebotomy site,
• having peripheral nerve disease,
• having peripheral neuropathy,
• patients with coagulation disorder,
• individuals who don't volunteered to participate in the study

Study Plan

How is the study designed?

Design Details

• Primary Purpose: Other
• Allocation: Randomized
• Interventional Model: Parallel Assignment
• Masking: None (Open Label)

Number of Arms

3

Arms and Interventions

Participant Group / Arm	Intervention / Treatment
Experimental: circular motion; The phlebotomy site was wiped in a circular motion from the center outwards, approximately 5x5 cm wide.	Other: circular motion; The phlebotomy site was wiped in a circular motion from the center outwards, approximately 5x5 cm wide.
Experimental: vertical motion; The phlebotomy site was wiped vertically from top to bottom with a single maneuver.	Other: vertical motion; The phlebotomy site was wiped vertically from top to bottom with a single maneuver.
Experimental: first vertical then circular motion; The phlebotomy site was first vertically wiped from top to bottom with a single maneuver, and then it was wiped in a circular motion from the center to the outside. Different swabs were used in both wipes.	Other: circular+vertical motion; The phlebotomy site was first vertically wiped from top to bottom with a single maneuver, and then it was wiped in a circular motion from the center to the outside.

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Vein Assessment	This evaluation has a total of 5 assessment steps, (1) veins are neither visible nor palpable, (2) veins are visible but not palpable, (3) veins are barely visible and palpable, (4) veins are visible and palpable, and (5) veins are clearly visible and easily palpable.	up to 1 minute after wiping the venipuncture site
Change in complications at 72 hours	The results of evaluations such as complication development and size of the complications. It was evaluated three times at the 24th, 48th and 72nd hours.	24th, 48th and 72nd hour

Collaborators and Investigators

• Sponsor: TC Erciyes University
• Investigators: Principal Investigator: SEVDA KORKUT, TC Erciyes University

Study record dates

Study Major Dates

• Study Start (Actual): July 1, 2020
• Primary Completion (Actual): May 28, 2021
• Study Completion (Actual): May 28, 2021

Study Registration Dates

• First Submitted: December 21, 2021
• First Submitted That Met QC Criteria: December 29, 2021
• First Posted (Actual): January 13, 2022

Study Record Updates

• Last Update Posted (Actual): January 26, 2022
• Last Update Submitted That Met QC Criteria: January 14, 2022
• Last Verified: January 1, 2022

More Information

Terms related to this study

• Other Study ID Numbers: 817

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No